News Details - Moderna
Mar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
Moderna Receives U.S. FDA Approval for Updated COVID-19 …
Sep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days.
Moderna Advances Multiple Vaccine Programs to Late-Stage …
Mar 27, 2024 · Announces positive clinical trial data from three new vaccines against viruses that cause significant burden (Epstein-Barr virus, Varicella-Zoster virus, norovirus) and advances programs toward Phase 3 development. Anticipates U.S. launch of vaccine against RSV following FDA approval and ACIP recommendation in 2024.
Moderna's combination Covid, flu vaccine is more effective than ...
Jun 10, 2024 · Moderna is the first company to release positive phase three data on a Covid and flu combination shot, giving it a lead over rivals Pfizer and Novavax.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
Sep 11, 2023 · FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
Moderna says 'bivalent' Covid booster provides stronger ... - NBC News
Jun 8, 2022 · A redesigned version of Moderna's Covid-19 booster shot appears to provide stronger protection against the omicron variant than its current vaccine, the company said in a news release...
News Details - Moderna
Oct 24, 2023 · mRNA-1083 is Moderna's first respiratory combination vaccine candidate to enter a Phase 3 trial. Phase 3 initiation follows data from a Phase 1/2 trial where mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccines.
Moderna Says Its Booster Significantly Raises Antibodies …
Dec 20, 2021 · A booster shot of the Moderna coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant, the company announced on Monday.
Moderna shares plunge on plans to cut $1.1 billion in costs, …
Sep 12, 2024 · Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.
Combined COVID–flu vaccines are coming: Moderna jab clears
Jun 28, 2024 · Moderna is now planning to seek approval from the US Food and Drug Administration (FDA) to bring the vaccine to market. Combination vaccines can have big public-health benefits, but they are...